Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Perrone

Showing results (21-30 of 272) with videos related to

Pageof 28
Sort By:
The New England Journal of Medicine|April 23, 2015
Adjuvant ovarian suppression in premenopausal breast cancerFilippo Montemurro, Francesco Perrone, Elena Geuna
The New England Journal of Medicine|February 22, 2002
Chemotherapy in the elderlyFrancesco Perrone, Ciro Gallo, Bruno Daniele
The Oncologist|December 25, 2019
Real-World Evidence in Oncology: Opportunities and LimitationsMassimo Di Maio, Francesco Perrone, Pierfranco Conte
Tumori|June 21, 2008
[Meta-analysis of phase III studies with palonosetron in the prevention of vomiting induced by moderately emetogenic chemotherapy]Massimo Di Maio, Ciro Gallo, Francesco Perrone
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2015
Reply to P. Baldo et alFrancesco Perrone, Massimo Di Maio, Ciro Gallo
Ebiomedicine|July 11, 2020
cfDNA testing for monitoring response to EGFR tyrosine kinase inhibitors: Time for clinical implementation?Nicola Normanno, Antonella De Luca, Francesco Perrone
Nature Reviews. Clinical Oncology|August 27, 2009
Targeted therapies: Role of sorafenib in HCC patients with compromised liver functionMassimo Di Maio, Bruno Daniele, Francesco Perrone
Recenti Progressi in Medicina|June 24, 2017
Francesco Perrone, Antonio Addis, Gianfranco Sinagra, et al.
Ecancermedicalscience|June 26, 2014
Exploratory research into cancer patients' attitudes to clinical trialsCorina W Ramers-Verhoeven, Francesco Perrone, Kathy Oliver
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|April 8, 2004
[Objectives of clinical experimentation in carcinoma of the lung]Francesco Perrone, Ermelinda De Maio, Massimo Di Maio
Pageof 28

Showing results (21-30 of 272) with videos related to

Sort By:
Pageof 28
The New England Journal of Medicine|April 23, 2015
Adjuvant ovarian suppression in premenopausal breast cancerFilippo Montemurro, Francesco Perrone, Elena Geuna
The New England Journal of Medicine|February 22, 2002
Chemotherapy in the elderlyFrancesco Perrone, Ciro Gallo, Bruno Daniele
The Oncologist|December 25, 2019
Real-World Evidence in Oncology: Opportunities and LimitationsMassimo Di Maio, Francesco Perrone, Pierfranco Conte
Tumori|June 21, 2008
[Meta-analysis of phase III studies with palonosetron in the prevention of vomiting induced by moderately emetogenic chemotherapy]Massimo Di Maio, Ciro Gallo, Francesco Perrone
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2015
Reply to P. Baldo et alFrancesco Perrone, Massimo Di Maio, Ciro Gallo
Ebiomedicine|July 11, 2020
cfDNA testing for monitoring response to EGFR tyrosine kinase inhibitors: Time for clinical implementation?Nicola Normanno, Antonella De Luca, Francesco Perrone
Nature Reviews. Clinical Oncology|August 27, 2009
Targeted therapies: Role of sorafenib in HCC patients with compromised liver functionMassimo Di Maio, Bruno Daniele, Francesco Perrone
Recenti Progressi in Medicina|June 24, 2017
Francesco Perrone, Antonio Addis, Gianfranco Sinagra, et al.
Ecancermedicalscience|June 26, 2014
Exploratory research into cancer patients' attitudes to clinical trialsCorina W Ramers-Verhoeven, Francesco Perrone, Kathy Oliver
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|April 8, 2004
[Objectives of clinical experimentation in carcinoma of the lung]Francesco Perrone, Ermelinda De Maio, Massimo Di Maio
Pageof 28